1. business and industrial
2. business operations
3. business plans

2015 Montana Pharmacy Association Winter CE & Ski Meeting
•
J A N U A RY 9–1 1
FACULTY
CRISTINA DUVALL, PHARMD; Friday Harbor Drug; Friday Harbor, WA
DONNA BEALL, PHARMD, BCPS, FCCP; UM Skaggs School of Pharmacy;
Missoula, MT
Big
NA!
IN MONTA
MEETING INFO
Norine Rice – MPA
PO Box 1569, Helena, MT 59624 • [email protected]
JENNIFER OTT, PHARMD, BCPS; Billings Clinic; Billings, MT
CHRISTIAN RAMERS, MD, MPH; Family Health Centers of San Diego; San
Diego, CA
CE INFO
Program Assistant, ACPE Programming
Skaggs School of Pharmacy at the University of Montana
[email protected] (406) 243-4621
LEE STRINGER, PHARMD, BCPS, CPE, FASCP; Billings Clinic; Billings, MT
Stuart Doggett or Norine Rice • MPA
PO Box 1569 • Helena, MT 59624
(406) 449-3843 • (406) 442-8018 (Fax)
[email protected] • [email protected]
BRITTNEY HOBBS, PHARM D, BCPS; St. Patrick Hospital; Missoula, MT
Skaggs School of Pharmacy at The University of Montana is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing pharmacy
education. This knowledge-based program is targeted to pharmacists. Activities listed
in this announcement have been approved for ACPE continuing education credit as
indicated. Individual activity descriptions include the amount of credit offered and
the Universal Activity Numbers. Statements of continuing education credits will
be submitted to CPE Monitor within 60 days, upon successful completion of the
verification of continuing education signature sheet and program evaluation form.
[email protected]
(406) 243-4621
Skaggs School of Pharmacy at the University of Montana
DONALD BROWN, PHARMD, BCACP, CPP; Billings Clinic; Billings, MT
Program Assistant, ACPE Programming
CE Information
JEANNIE SWAIN, PHARMD; St. Patrick Hospital; Missoula, MT
Meeting Information
MELANIE TOWNSEND, PHARMD, BCPS; Billings Clinic; Billings, MT
LIVE
LOCATION AND RESERVATIONS
Big Sky Resort, Big Sky, Montana
For reservations call: 406.995.5750 or 800.548.4486
Reserve by 12.21.14 and say you are with the MPA
conference to receive the MPA rate.
Room Block Releases Dec. 21, 2014 and no room
cancellations after December 9th.
JOSEPH HILL, MA; Governmental Affairs, ASHP; Bethesda, MD
KATHERINE HALE, PHARMD, BCPS; UM Skaggs School of Pharmacy;
Missoula, MT
B I G SK Y, M O NTANA
Make your reservations by January 8, 2008 and tell them you are with the MPA Conference to receive the block rate of $99/night.
Fairmont Hot Springs Resort • Located Outside of Anaconda
Make your reservations by calling: (800) 332-3272 or (406) 797-3241
LINDA GARRELTS MACLEAN, BS PHARM, CDE, APHA; Spokane, WA
NOTE – Disclosure of Potential Conflicts of Interest: Skaggs
School of Pharmacy at The University of Montana did not receive
payment or services from a third party for any aspect of this
activity and has no relationships (financial or other) with entities
or activities that could be perceived to influence or that give the
appearance of potentially influencing any portion of this activity.
Location and Reservations
STUART DOGGETT, Executive Director; MPA; Helena, MT
TONY KING, PHARMD, CHAIR & CHAIR LEGISLATIVE/POLICY COMMITTEE;
Walgreens; Missoula, MT
Montana Pharmacy Association
TECHNICIAN IMMUNIZATION PROGRAM:
Lisa Barnes, MBA B.Pharm., Skaggs School of Pharmacy, Missoula, Montana
Faculty
WINTER CE + SKI MEETING
JANUARY 9–11, 2015 BIG SKY, MONTANA
PROGRAM OVERVIEW
Montana Ph
Winter CE/
The 2015 Winter Continuing Education (CE) Conference, held at the beautiful
Janu
Big Sky Resort, will offer a total of 15 CE hours for pharmacists and technicians
Fairmont Hot Springs
attending all 3 meeting days. The program sessions will include topics relevant
to various pharmacy practices setting including hospital, ambulatory care,
Pharmaci
and community. Clinical experts will speak on topics including pharmacist
The goal of this conference is to
provider status, infectious diseases, acute and chronic pain management,
with current practice
hypertension and lipid management, reversal of new anticoagulants, and the
pharmacist’s role in prescription drug abuse. Additionally, the Program
conference Overview
will include updates on the MPA Health-Systems Academy and a review of
The 2008 Winter Continuing Education Conference will in- Ph
state and national issues affecting the pharmacy profession. clude 7 hours of continuing education addressing several im- co
portant topics
Each year, generous participants sponsor students and technicians
to of current interest to practicing pharmacists.
Participants
will learn about current clinical and drug therapy
attend this educational and networking opportunity. To provide
a donation
2015 as relevant legisissues in heart failure and diabetes, as well
for others to participate in the Winter CE meeting, please indicate your
lative and regulatory issues affecting the profesion.
preference on the registration form.
C E & Ski
Enjoy the slopes at the world-renowned Big Sky Resort
or take advantage of the many other local activities while
sharpening practice skills, enhancing business strategies,
networking, and connecting with colleagues.
Presented in collaboration with:
Skaggs School of Pharmacy
ph
vi
Th
stu
En
A
an
an
kn
se
Associate Professor, Pharmacy Administration, Purdue University, School of Pharmacy and Pharmaceutical Sciences,
West Lafayette, Indiana
Matthew M. Murawski, Ph.D.
Pharmaceutical Care Coordinator, Internal Medicine, Lovelace Medical Center, Alburquerque, New Mexico
Ernest J. Dole, Pharm. D., BCPS, FASHP
Attending Physician, Kootenai Medical Center, Coeur d’Alene, Idaho
Mark Kinney, R.Ph., Independent Pharmacy Cooperative, Louisville, Colorado
Bradley D. Berry, MD, Board Certified in Cardiology, University of Minnesota, Minneapolis, Minnesota
Gary Meyers, Pharm. D., Deering Clinic, Billings, Montana
Chris Corsi, MD, Board Certified Endocrinologist
Winter CE/Ski/Swim Conference • January 25 - 27, 2008 • Fairmont Hot Springs
LIVE
Big
IN MONTANA!
Montana Pharmacy Association
PO Box 1569
Helena, MT 59624
(406) 449-3843
2008 Winter CE Conference
2015 Winter CE Conference
Montana Pharmacy Association
PO Box 1569
Helena, MT 59624
(406) 449-3843
PRESORTED STD
U.S. POSTAGE PAID
HELENA, MT 59601
PERMIT #221
GOALS & OBJECTIVES
RECOGNIZING PHARMACISTS AS PROVIDERS,
FILLING AN UNMET PATIENT NEED
Joseph Hill, MA; Governmental Affairs, ASHP;
Bethesda, MD
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Describe HR 4190 and its intent as well as
describe how it will impact pharmacy.
2.Discuss the Patient Access to Pharmacists Care
Coalition and who comprises it.
3.Explain the coalition’s efforts to secure provider
status and seek support for HR 4190.
PETS ARE PEOPLE TOO: INTERSPECIES
MEDICATIONS
Cristina DuVall, PharmD; Friday Harbor Drug; Friday
Harbor, WA
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Compare basic anatomical features between
humans and common domesticated animals.
2.List medications frequently prescribed for
multiple species.
3.Describe medication administration techniques
for various creatures.
A POSITIVE PPD – WHAT NOW? THE ROLE
OF PHARMACISTS IN LATENT TB INFECTION
Donna Beall, PharmD, BCPS, FCCP; UM Skaggs
School of Pharmacy; Missoula, MT
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.List who should be screened for LTBI.
2.Discuss methods to optimize adherence to LTBI
medication.
3.Articulate the potential role of a pharmacist in
managing LTBI.
RECENTLY APPROVED DRUGS FOR
INFECTIOUS DISEASE
Jennifer Ott, PharmD, BCPS; Billings Clinic;
Billings, MT
OBJECTIVES: At the conclusion of the
presentation, pharmacists should be able to:
1.Explain the antibiotic pipeline.
2. Discuss the clinical indications, pharmacokinetics,
spectrums of activity, and adverse effects
associated with the new antimicrobial agents.
3.Describe the clinical trial data associated
tedizolid, dalbavancin, oritavancin and
ceftolozane/tazobactam.
4.Identify the place in therapy for each of the new
antimicrobial agents.
OBJECTIVES FOR TECHNICIANS:
1.Explain the antibiotic pipeline.
2. List the newly approved antibiotics and describe
what antibiotic class they belong to.
HIV/HCV UPDATE 2015
Christian Ramers, MD, MPH; Family Health Centers of
San Diego; San Diego, CA
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Identify recent changes in DHHS guidelines
expanding the use of integrase inhibitors in the
treatment of HIV infection.
2.Describe the remarkable improvement in efficacy
and tolerability of HCV treatment regimens.
3.List important considerations in identifying HCV
treatment candidates.
4.Discuss practical aspects of successfully
obtaining current therapies.
SAILING THE SEAS OF NOCICEPTION:
FROM ACUTE TO PERSISTENT PAIN AND
BACK AGAIN
Brittney Hobbs, Pharm D, BCPS; St. Patrick Hospital;
Missoula, MT
Lee Stringer, PharmD, BCPS, CPE, FASCP; Billings
Clinic; Billings, MT
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Recall definitions related to acute pain, persistent
pain, and addiction.
2.Describe the tools and questions available to utilize
while assessing your patient for acute pain.
3.Describe the challenges of treating acute pain in
patients receiving chronic opioid therapy.
BRINGING BLOOD PRESSURE DOWN:
COMMUNITY PHARMACY TEAMS UP
Katherine Hale, PharmD, BCPS: UM Skaggs School of
Pharmacy
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Describe the role of the community pharmacist
in the prevention, education, and management of
hypertension.
2.Discuss the results of the Montana Team Up,
Pressure Down Community Pharmacy project.
3. Discuss the implementation and results
of community-based hypertension selfmanagement education programs.
LIPID MANAGEMENT GUIDELINES
Donald Brown, Pharm.D, BCACP, CPP; Billings Clinic;
Billings, MT
Objectives: At the conclusion of the
presentation, participants should be able to:
1.List current medications available for cholesterol
lowering, including some herbal products.
2.Discuss the new guidelines and controversy
associated with them.
3.Discuss how these guidelines may or may not
affect quality measures.
AGENDA
KEEPING THE BALL ROLLING: MONTANA
PHARMACY ASSOCIATION HEALTH SYSTEMS
ACADEMY UPDATE
Melanie Townsend, PharmD, BCPS; Billings Clinic;
Billings, MT
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.List 2 or more strategic goals for the Academy in
2014 – 2015.
2.Discuss the benefits of affiliation between the
Academy and ASHP.
3.Describe avenues for involvement within the
Academy.
EMERGENT REVERSAL OF
ANTICOAGULATION
Jeannie Swain, PharmD; St. Patrick Hospital;
Missoula, MT
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.Review common anticoagulation agents & their
mechanisms of action.
2.Describe circumstances that necessitate
emergent reversal of anticoagulants.
3.Explain current agents available to reverse
anticoagulation & their mechanism of action.
A NATIONAL PERSPECTIVE: FEDERAL
POLICY AFFECTING PHARMACISTS
Linda Garrelts MacLean, BS Pharm, CDE, APhA
OBJECTIVES: At the conclusion of the
presentation, participants should be able to
1.Identify various efforts underway to help curtail
prescription drug abuse, misuse and diversion.
2.List the recent Drug Enforcement Administration
actions related to controlled substances and
prescription drug tack back.
3.Describe the impact of recent federal legislation
and regulation on pharmacy practice.
CURRENT LAW AND PRACTICE ISSUES
IN THE STATE & NATION
Stuart Doggett, Executive Director; MPA; Helena, MT
Tony King, PharmD, Chair & Chair Legislative/Policy
Committee; MPA; Helena, MT
OBJECTIVES: At the conclusion of the
presentation, participants should be able to:
1.List two legislative initiatives MPA will seek to
pass during the 2015 legislature.
2.Identify one recent change to Administrative Rule
passed by the Montana Board of Pharmacy.
3.Identify one primary federal initiative being
worked on by national pharmacy representatives.
FRIDAY, JANUARY 9, 2015
9:00 a.m.
1:00 p.m.
2:00 p.m.
9:15 a.m.-4:00 p.m.
3:00-4:00 p.m.
5:30-6:30 p.m.
6:30-7:30 p.m.
Board of Pharmacy Meeting
MPA Health-Systems Academy Meeting
MPA Board Meeting
Ski or Recreational Activities
Vendor Set-Up and Registration
Social Hour and Visit Your Vendor
Dinner
7:00-8:45 p.m.
Recognizing Pharmacists as Providers,
Filling an Unmet Patient Need
Joseph Hill, MA; Government Affairs, ASHP
8:45 p.m.-9:00 p.m. Questions, Post-Test, and Evaluation
7:00-8:30 p.m.
Hors d’oeurvres and Sports Viewing.
Wear your favorite sports team attire!
SUNDAY, JANUARY 11, 2015
7:30-8:00 a.m.
Breakfast
CONCURRENT SESSION I
8:00-9:45 a.m.
Community Pharmacy
Bringing Blood Pressure Down: Community Pharmacy Teams Up
Katherine Hale, PharmD, BCPS; UM Skaggs School
of Pharmacy
Lipid Management Guidelines
9:45- 10:00 a.m.
Questions, Post Test, Evaluation
Donald Brown, PharmD, BCACP, CPP; Billings Clinic
CONCURRENT SESSION II
SATURDAY, JANUARY 10, 2015
6:30-7:00 a.m.
Breakfast in Vendor Area
8:00-9:45 a.m.
Health-System Pharmacy
Keeping the Ball Rolling: Montana Pharmacy Association
Health-Systems Academy Update
INFECTIOUS DISEASES
Melanie Townsend, PharmD, BCPS; Billings Clinic
7:00-7:45 a.m.
Pets are People Too: Interspecies Medications
Emergent Reversal of Anticoagulation
7:45-8:00 a.m.
Questions, Post Test, and Evaluation
9:45-10:00 a.m.
Questions, Post Test, Evaluation
10:00-10:15 a.m.
Break
10:15-11:00 a.m.
A National Perspective:
Federal Policy Affecting Pharmacists
8:00-8:45 a.m. Cristina DuVall, PharmD; Friday Harbor Drug
A Positive PPD – What Now?
The Role of Pharmacists in Latent TB Infection
Donna Beall, PharmD, BCPS;
UM Skaggs School of Pharmacy
Jeannie Swain, PharmD; St. Patrick Hospital
Linda Garrelts MacLean, BS Pharm, CDE; APhA
8:45-9:00 a.m.
Questions, Post Test, Evaluation
11:00-11:15 a.m.
Questions, Post Test, Evaluation
9:00-9:15 a.m.
Break in Vendor Area
11:15-1:00 p.m.
INFECTIOUS DISEASES CONTINUED
Current Law and Practice Issues
in the State & Nation
9:15-10:00 a.m.
Recently Approved Drugs for Infectious Disease
1:00-1:15 p.m. Questions, Post Test, Evaluation
10:00-10:15 a.m.
Questions, Post Test, Evaluation
1:15-1:30 p.m.
Conference Evaluation
10:15-12:00 p.m.
HIV/HCV Update 2015
12:00-12:15 p.m.
Questions, Post Test, Evaluation
12:15-1:45 p.m.
Lunch and Pharmacy Leaders’ Discussion: Spotlight on Technicians
1:45 p.m.
Vendors Break Down
Jennifer Ott, PharmD, BCPS; Billings Clinic
Christian Ramers, MD, MPH;
Family Health Centers of San Diego
Facilitated by Melanie Townsend, Jennifer Schultz
and Angela Jensen
PAIN MANAGEMENT
4:00-6:45 p.m.
Sailing the Seas of Nociception:
From Acute to Persistent Pain and Back Again
6:45-7:00 p.m.
Questions, Post Test, Evaluation
Brittney Hobbs, PharmD, BCPS; St. Patrick Hospital
Lee Stringer, PharmD, BCPS, CPE; Billings Clinic
Stuart Doggett, Executive Director; MPA and Tony King, PharmD, Chair & Chair of Legislative Committee; MPA